Monogram Orthopaedics (NASDAQ:MGRM – Get Free Report) is scheduled to post its quarterly earnings results after the market closes on Tuesday, November 19th. Analysts expect Monogram Orthopaedics to post earnings of ($0.12) per share for the quarter.
Monogram Orthopaedics (NASDAQ:MGRM – Get Free Report) last issued its earnings results on Thursday, August 15th. The company reported ($0.11) EPS for the quarter, missing the consensus estimate of ($0.09) by ($0.02). During the same quarter in the prior year, the business posted ($0.27) EPS. On average, analysts expect Monogram Orthopaedics to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.
Monogram Orthopaedics Stock Up 2.0 %
Shares of Monogram Orthopaedics stock opened at $2.05 on Friday. The stock has a market capitalization of $71.12 million, a P/E ratio of -4.36 and a beta of 2.28. Monogram Orthopaedics has a 12-month low of $1.53 and a 12-month high of $4.90. The company has a 50-day simple moving average of $2.51 and a 200 day simple moving average of $2.37.
Monogram Orthopaedics Company Profile
Monogram Orthopaedics, Inc focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures.
See Also
- Five stocks we like better than Monogram Orthopaedics
- 3 Best Fintech Stocks for a Portfolio Boost
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
- How to Choose Top Rated Stocks
- Freeport-McMoRan, Copper Demand Short-Term Pain, Long-Term Gain
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Time to Load Up on Home Builders?
Receive News & Ratings for Monogram Orthopaedics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monogram Orthopaedics and related companies with MarketBeat.com's FREE daily email newsletter.